BUSINESS
Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
Takeda Pharmaceutical could complete its acquisition of London-listed Shire as early as January 8 if the proposed takeover clears an extraordinary shareholders meeting now slated for early December. The Japanese drug juggernaut said on November 12 that it has decided…
To read the full story
Related Article
- Takeda Shareholders OK £46 Billion Shire Takeover
December 5, 2018
BUSINESS
- Nipro’s Stemirac Clinches Full Approval in Japan
November 17, 2026
- Kyorin Bags Japan Rights to Acadia’s Rett Syndrome Drug
November 17, 2026
- Eisai, J&J, Takeda among Firms Rolling Out Newly Listed Medicines in Japan
November 16, 2026
- Fuji Poised to Hit 10 Billion Yen Biosimilar Sales Mark, Led by Eylea Follow-On
November 16, 2026
- Seikagaku Sees Over a Year Before US Refiling of Herniated Disk Drug
November 16, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





